193 related articles for article (PubMed ID: 22113479)
21.
Erf GF; Le Pape G; Rémy S; Denesvre C
Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33092272
[TBL] [Abstract][Full Text] [Related]
22. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
23. Herpesvirus connection in the expression of autoimmune vitiligo in Smyth line chickens.
Erf GF; Bersi TK; Wang X; Sreekumar GP; Smyth JR
Pigment Cell Res; 2001 Feb; 14(1):40-6. PubMed ID: 11277493
[TBL] [Abstract][Full Text] [Related]
24. Avian models with spontaneous autoimmune diseases.
Wick G; Andersson L; Hala K; Gershwin ME; Selmi C; Erf GF; Lamont SJ; Sgonc R
Adv Immunol; 2006; 92():71-117. PubMed ID: 17145302
[TBL] [Abstract][Full Text] [Related]
25. Dimethyl fumarate-induced IL-17
Brück J; Glocova I; Geisel J; Kellerer C; Röcken M; Ghoreschi K
Eur J Immunol; 2018 Sep; 48(9):1588-1591. PubMed ID: 30007005
[TBL] [Abstract][Full Text] [Related]
26. Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.
Kim BJ; Jones HP
Brain Behav Immun; 2010 Oct; 24(7):1126-36. PubMed ID: 20621581
[TBL] [Abstract][Full Text] [Related]
27. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.
Cavalli G; Hayashi M; Jin Y; Yorgov D; Santorico SA; Holcomb C; Rastrou M; Erlich H; Tengesdal IW; Dagna L; Neff CP; Palmer BE; Spritz RA; Dinarello CA
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1363-8. PubMed ID: 26787888
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
30. Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity.
Rahimi A; Hossein-Nataj H; Hajheydari Z; Aryanian Z; Shayannia A; Ajami A; Asgarian-Omran H
Exp Dermatol; 2019 Jun; 28(6):674-681. PubMed ID: 31046170
[TBL] [Abstract][Full Text] [Related]
31. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
32. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression.
Jin Y; Roberts GHL; Ferrara TM; Ben S; van Geel N; Wolkerstorfer A; Ezzedine K; Siebert J; Neff CP; Palmer BE; Santorico SA; Spritz RA
Nat Commun; 2019 Jan; 10(1):391. PubMed ID: 30674883
[TBL] [Abstract][Full Text] [Related]
33. Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus.
Debes GF; Dahl ME; Mahiny AJ; Bonhagen K; Campbell DJ; Siegmund K; Erb KJ; Lewis DB; Kamradt T; Hamann A
J Immunol; 2006 Jan; 176(1):557-66. PubMed ID: 16365450
[TBL] [Abstract][Full Text] [Related]
34. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
35. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
36. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
37. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.
Heinzel FP; Sadick MD; Mutha SS; Locksley RM
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
Sarra M; Monteleone I; Stolfi C; Fantini MC; Sileri P; Sica G; Tersigni R; Macdonald TT; Pallone F; Monteleone G
Inflamm Bowel Dis; 2010 Aug; 16(8):1332-9. PubMed ID: 20186935
[TBL] [Abstract][Full Text] [Related]
39. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
[TBL] [Abstract][Full Text] [Related]
40. The detection of melanocyte autoantibodies in the Smyth chicken model for vitiligo.
Austin LM; Boissy RE; Jacobson BS; Smyth JR
Clin Immunol Immunopathol; 1992 Aug; 64(2):112-20. PubMed ID: 1643744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
